Compare ALTG & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALTG | STXS |
|---|---|---|
| Founded | 1984 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 226.0M | 210.0M |
| IPO Year | N/A | 2004 |
| Metric | ALTG | STXS |
|---|---|---|
| Price | $6.64 | $1.99 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $11.33 | $4.00 |
| AVG Volume (30 Days) | 217.6K | ★ 494.1K |
| Earning Date | 03-04-2026 | 03-09-2026 |
| Dividend Yield | ★ 0.86% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,824,900,000.00 | $30,075,000.00 |
| Revenue This Year | N/A | $24.21 |
| Revenue Next Year | $3.40 | $29.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 19.62 |
| 52 Week Low | $3.54 | $1.54 |
| 52 Week High | $8.99 | $3.59 |
| Indicator | ALTG | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 53.73 | 31.58 |
| Support Level | $6.46 | $1.97 |
| Resistance Level | $7.56 | $2.16 |
| Average True Range (ATR) | 0.38 | 0.12 |
| MACD | -0.06 | -0.03 |
| Stochastic Oscillator | 18.58 | 3.65 |
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.